direkt zum Inhalt springen

direkt zum Hauptnavigationsmenü

Sie sind hier

TU Berlin

Inhalt des Dokuments

2020 [1] | 2019 [2] | 2018 [3] | 2017 [4] | 2016 [5] | 2015 [6] | 2014 [7] | 2013 [8] | 2012 [9] | 2011 [10] | 2010 [11] | 2009 [12] | 2008 [13] | 2007 [14] | 2006 [15] | 2005 [16] | 2004 [17] | 2003 [18] | 2002 [19]

Vorträge 2014

Lupe [20]

Fallzahlsteigerungen im Gesundheitswesen - Impulsreferat - [21]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Berlin 02.12.2014

Lupe [22]

Auf dem Weg zu einem evidenzbasierten Gesundheitssystem [23]
Video [24]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Köln 28.11.2014

Lupe [25]
Lupe [26]

Diagnosis Related Groups in Europe: Adaptations and trends [27]
Diagnosis Related Groups en Europe: Adaptations et tendances [28]
W. Quentin
Genf 26.11.2014

Lupe [29]

Europäische Gesundheitssysteme im Vergleich – wo stehen wir? [30]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Offenbach 25.11.2014

“Living up to Improved Performance” - The role of international projects [31]
Britta Zander
Eupha 22.11.2014

Lupe [32]

Provision of health services: Trends and patterns in Europe (EU 28 + Iceland, Norway and Switzerland) [33]
W. Quentin, J. Cylus, A. Geissler, A. Maresso, S. Merkur, G. Pastorino, A. Sagan
Glasgow 21.11.2014

Lupe [34]

Gesundheitspolitik in Europa aus wissenschaftlicher Sicht [35]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Berlin 17.11.2014

Lupe [36]

Hospital payment and Diagnosis - Related Groups in Germany - Boone or Bane? [37]
Alexander Geissler, Dr.
Dubrovnik 14.11.2014

Lupe [38]

Vorstellung und Diskussion des “Health Systems in Transition” (HiT)-Profils Deutschland 2014 [39]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Berlin 14.11.2014

Lupe [40]

Forschungsauftrag zur Mengenentwicklung im Krankenhaus nach § 17b Abs. 9 KHG: Ergebnisse und Empfehlungen [41]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Berlin 27.10.2014

Lupe [42]

DRGs: Are hospitals paid for what they do – or do they do for what they are paid? And why patients should care about it [43]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Doha 21.10.2014

Lupe [44]

Medical devices: a taxonomy suitable for HTA [45]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Warschau 26.09.2014

Lupe [46]

Medical devices: differences vs. other technologies, especially pharmaceuticals [47]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Warschau 26.09.2014

Lupe [48]

Qualitätsinstitute im internationalen Vergleich [49]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Berlin 22.09.2014

Lupe [50]

Inequalities in Health and Health Care [51]
Martin Siegel, Dr.
Dresden 22.09.2014

Lupe [52]

Exploring barriers and dilemmas for the adoption of cost containment strategies in the economic, institutional and political environment [53]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Brüssel 17.09.2014

Lupe [54]

Sicherstellung der Versorgung – brauchen wir einen neuen ordnungspolitischen Rahmen? [55]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Berlin 16.09.2014

Lupe [56]

The German health system: basics and some comparisons with other countries [57]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Berlin 16.09.2014

Lupe [58]

Rettungsdienstliche Versorgung in Deutschland (EMSiG) [59]
Natalie Götz
Berlin 11.09.2014

Lupe [60]

From a conservative to a liberal welfare state: decomposing changes in income-related health inequalities in Germany, 1994-2011 [61]
Martin Siegel, Dr.
Dublin 16.07.2014

Lupe [62]

Towards a taxonomy of medical devices in the logic of HTA and economic evaluations rather than marketing authorization [63]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Dublin 15.07.2014

A taxonomy of medical devices in the logic of HTA [64]
Dimitra Panteli
Washington 16.06.2014

Equity considerations among HTA agencies –current practice and ways forward [65]
Dimitra Panteli
Washington 16.06.2014

The role of dissemination bias in pharmaceutical coverage decisions: an analysis of practices in European countries [66]
Dimitra Panteli
Washington 16.06.2014

The process of evidence-based decision-making for the reimbursement and pricing of pharmaceuticals in Europe: mapping approaches in 36 countries [67]
Dimitra Panteli
Washington 16.06.2014

Lupe [68]

Weiterentwicklung der Darmkrebsfrüherkennung: Themenbereich organisiertes Einladungsverfahren – Impulsreferat [69]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Berlin 23.05.2014

Lupe [70]

Deutsche Krankenhäuser im europäischen Vergleich – Ergebnisse des EuroDRG-Projektes: Wo stehen wir bezüglich Leistungsspektrum, Kosten und Qualität? [71]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Berlin 15.05.2014

Lupe [72]

Intoduction to the healthcare ecosystem and cost factors [73]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Paris 05.05.2014

Lupe [74]

The Health Systems and Policy Monitor (HSPM) [75]
Wilm Quentin, Dr. med MSc HPPF
Brazzaville 29.04.2014

Lupe [76]

The European Observatory on Health Systems and Policies [77]
Wilm Quentin, Dr. med MSc HPPF
Brazzaville 28.04.2014

Lupe [78]

Sinn und Unsinn von Leistungsvergleichen im Krankenhaus – Erfolgskriterien, Bewertung und Referenzgrößen auf nationaler und internationaler Ebene [79]
Reinhard Busse, Prof. Dr. med. MPH FFPH
München 18.04.2014

Lupe [80]

Pharmaceutical pricing, reimbursement, HTA and cost containment measures in Europe: an overview (II) [81]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Beijing 11.04.2014

Lupe [82]

Pharmaceutical pricing, reimbursement, HTA and cost containment measures in Europe: an overview (I) [83]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Beijing 11.04.2014

Lupe [84]

Health care reform and pharmaceutical policies in Germany [85]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Beijing 11.04.2014

Lupe [86]

Addressing emerging patient needs:from free choice to integrated care [87]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Brüssel 21.03.2014

Lupe [88]

DRGs und krankheitsbezogenes Management in der stationären Versorgung aus internationaler Perspektive [89]
Reinhard Busse, Prof. Dr. med. MPH FFPH
München 18.03.2014

Lupe [90]

Hospital payment and DRGs in Germany: The G-DRG system [91]
Wilm Quentin, Dr. med MSc HPPF
Warschau 18.03.2014

Lupe [92]

Hat sich gesundheitliche Ungleichheit in Ost- und Westdeutschland seit der Wiedervereinigung unterschiedlich entwickelt? Ein Vergleich anhand der Zerlegung von Konzentrationsindizes [93]
Martin Siegel, Dr.
München 18.03.2014

Lupe [94]

The effect of continuity of ambulatory care on hospitalizations in patients with heart failure [95]
Verena Vogt
München 17.03.2014

Lupe [96]

Der Einfluss von Wettbewerb zwischen Krankenhäusern auf die Mengenentwicklung bei orthopädischen Operationen [97]
Natalie Götz
München 17.03.2014

Lupe [98]

The Latvian Health System [99]
Uldis Mittenbergs & Wilm Quentin
Brüssel 07.03.2014

Lupe [100]

Regulation and governance of providers (especially hospitals) [101]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Jerusalem 04.03.2014

Lupe [102]

DRGs in Europe: towards transparency, efficiency, and quality of hospital care? [103]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Jerusalem 04.03.2014

Lupe [104]

Postoperative kognitive Störungen aus Public Health-Sicht [105]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Berlin 28.02.2014

Lupe [106]

Implementing competitive UHI: benefit basket, pooling, risk-related allocation and other important considerations [107]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Dublin 23.01.2014

Lupe [108]

The financing function: Raising, pooling and allocating resources [109]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Paris 21.01.2014

Lupe [110]

Differences in health care structure and incentives – do they worsen or reduce health inequalities? (… and a framework to examine access to health care …) [111]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Paris 21.01.2014

Lupe [112]

Health system reforms in times of crisis: EU countries [113]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Paris 21.01.2014

------ Links: ------

Zusatzinformationen / Extras

Direktzugang

Schnellnavigation zur Seite über Nummerneingabe

Copyright TU Berlin 2008